Join Growin Stock Community!

永信3705.TW Overview

TW StockBiotech. & Medical
(No presentation for 3705)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

永信（3705）Overall Performance

永信（3705）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

永信（3705） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

永信（3705）Key Information

永信（3705）Profile

YungShin Global Holding Corporation, through its subsidiaries, engages in the investment, manufacture, and sale of medicines, animal drugs, agricultural chemicals, industrial medicine, and cosmetics in Taiwan, Mainland China, Japan, and the United States. The company engages in the extraction, manufacture, and sale of wood products; manufacture and sale of over-the-counter drugs, preparations, and chemical intermediates; and pharmaceutical research, transfer, authorization, and outsourcing of services, as well as import and export trading. In addition, it is involved in the trading, wholesale, and retail of health products, cosmetics, medicines, human testing reagents, and the aforesaid related raw materials; semi-finished products; and production equipment. The company was founded in 1952 and is based in Taichung, Taiwan.

永信（3705）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
3.61
PE Ratio (TTM)
15.21
Forward PE
19.37
PS Ratio (TTM)
1.75
PB Ratio
1.71
Price-to-FCF
29.06
METRIC
VALUE
vs. INDUSTRY
Gross Margin
43.33%
Net Margin
11.50%
Revenue Growth (YoY)
10.66%
Profit Growth (YoY)
11.43%
3-Year Revenue Growth
-0.75%
3-Year Profit Growth
-4.67%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
3.61
PE Ratio (TTM)
15.21
Forward PE
19.37
PS Ratio (TTM)
1.75
PB Ratio
1.71
Price-to-FCF
29.06
Gross Margin
43.33%
Net Margin
11.50%
Revenue Growth (YoY)
10.66%
Profit Growth (YoY)
11.43%
3-Year Revenue Growth
-0.75%
3-Year Profit Growth
-4.67%
default symbol

3705

永信

55.00D

0.00%

(0.00)

  • When is 3705's latest earnings report released?

    The most recent financial report for 永信 (3705) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 3705's short-term business performance and financial health. For the latest updates on 3705's earnings releases, visit this page regularly.

  • Where does 3705 fall in the P/E River chart?

    According to historical valuation range analysis, 永信 (3705)'s current price-to-earnings (P/E) ratio is 13.27, placing it in the Watch zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning optimistic. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of 3705?

    According to the latest financial report, 永信 (3705) reported an Operating Profit of 241.05M with an Operating Margin of 12.61% this period, representing a decline of 29.59% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is 3705's revenue growth?

    In the latest financial report, 永信 (3705) announced revenue of 1.91B, with a Year-Over-Year growth rate of -9.13%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does 3705 have?

    At the end of the period, 永信 (3705) held Total Cash and Cash Equivalents of 1.27B, accounting for 0.11 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 3705 go with three margins increasing?

    In the latest report, 永信 (3705) achieved the “three margins increasing” benchmark, with a gross margin of 41.89%%, operating margin of 12.61%%, and net margin of 10.98%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 3705's profit trajectory and future growth potential.

  • Is 3705's EPS continuing to grow?

    According to the past four quarterly reports, 永信 (3705)'s earnings per share (EPS) shows a declining trend, with the latest EPS at 0.73. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of 3705?

    永信 (3705)'s Free Cash Flow (FCF) for the period is -259.21M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 94.65% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.